|
LIXT Lixte Biotechnology Holdings Inc 1335105 |
| Income Statement |
|
Net Income
|
2025-12-31
|
$-6,078,593.00 |
| Balance Sheet |
|
Current Assets
|
$3,407,750.00 |
|
Assets
|
$10,865,298.00 |
|
Current Liabilities
|
$1,224,934.00 |
|
Liabilities
|
$1,686,706.00 |
|
Equity
|
$7,945,032.00 |
|
Shares Out
|
11632944.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,831,363.00 |
|
Investing Cash Flow
|
$-24,859.00 |
| Market Analysis |
Market Cap
|
$83,873,526.24 |
|
Price
|
$7.21 |
|
BVPS
|
0.68 |
|
PB
|
10.60 |
|
EPS
|
-0.18 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:37 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:35 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LIXT documents filed with the SEC.
LIXT Filings
Clear
